Search results for "imidazoles"

showing 10 items of 272 documents

The role of the dual nature of ionic liquids in the reversed-phase liquid chromatographic separation of basic drugs.

2010

The cationic nature of basic drugs gives rise to broad asymmetrical chromatographic peaks with conventional C18 columns and hydro-organic mixtures, due to the ionic interaction of the positively charged solutes with the free silanol groups on the alkyl-bonded reversed-phase packing. Ionic liquids (ILs) have recently attracted some attention to reduce this undesirable silanol activity. ILs are dual modifiers (with a cationic and anionic character), which means that both cation and anion can be adsorbed on the stationary phase, giving rise to interesting interactions with the anionic free silanols and the cationic basic drugs. A comparative study of the performance of four imidazolium-based I…

TetrafluoroborateIonic bondingIonic LiquidsBiochemistryAnalytical Chemistrychemistry.chemical_compoundPhase (matter)BoratesEthylaminesTriethylamineChromatography Reverse-PhaseChromatographyOrganic ChemistryCationic polymerizationImidazolesSodium Dodecyl SulfateGeneral MedicineReversed-phase chromatographyHydrogen-Ion ConcentrationSilanesSilanolchemistryModels ChemicalPharmaceutical PreparationsIonic liquidLinear ModelsJournal of chromatography. A
researchProduct

Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects.

2012

Up-regulation of the folding machinery of the heat-shock protein 90 (Hsp90) chaperone protein is crucial for cancer progression. The two Hsp90 isoforms (α and β) play different roles in response to chemotherapy. To identify isoform-selective inhibitors of Hsp90(α/β)/cochaperone p23 interactions, we developed a dual-luciferase (Renilla and Firefly) reporter system for high-throughput screening (HTS) and monitoring the efficacy of Hsp90 inhibitors in cell culture and live mice. HTS of a 30,176 small-molecule chemical library in cell culture identified a compound, N -(5-methylisoxazol-3-yl)-2-[4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio]acetamide (CP9), that binds to Hsp90(α/β) an…

Thymidine kinase activityProtein FoldingImmunoprecipitationLactams MacrocyclicBlotting WesternMice NudeThiophenesBiologyThioacetamideTritiumSmall Molecule LibrariesMiceco-chaperone p23Luciferases FireflyHeat shock proteinCell Line TumorNeoplasmsAcetamidesDrug DiscoveryBenzoquinonesAnimalsHumansImmunoprecipitationProtein IsoformsLuciferaseHSP90 Heat-Shock ProteinsLuciferases RenillaProstaglandin-E SynthasesMultidisciplinaryCell growthImidazolesbioluminescence imagingHsp90Small moleculeMolecular biologydrug developmentHigh-Throughput Screening Assayssmall-molecule inhibitorsIntramolecular OxidoreductasesLeadPNAS PlusCell culturePositron-Emission TomographyPyrazinesbiology.proteinPET/computed tomography imagingTomography X-Ray ComputedProceedings of the National Academy of Sciences of the United States of America
researchProduct

REDUCTION OF NILUTAMIDE BY NO SYNTHASES : IMPLICATIONS FOR THE ADVERSE EFFECTS OF THIS NITROAROMATIC ANTIANDROGEN DRUG

2003

Nitric oxide synthases (NOSs) are flavohemeproteins that catalyze the oxidation of l-arginine to l-citrulline with formation of the widespread signal molecule NO. Beside their fundamental role in NO biosynthesis, these enzymes are also involved in the formation of reactive oxygen species and in the interactions with some xenobiotic compounds. Nilutamide is a nonsteroidal antiandrogen that behaves as a competitive antagonist of the androgen receptors and is proposed in the treatment of metastatic prostatic carcinoma. However, therapeutic effects of nilutamide are overshadowed by the occurrence of several adverse reactions mediated by toxic mechanism(s), which remain(s) poorly investigated. H…

Time FactorsFree RadicalsNitric Oxide Synthase Type IIImedicine.drug_class[CHIM.THER] Chemical Sciences/Medicinal ChemistryNitric Oxide Synthase Type IINitric Oxide Synthase Type I[CHIM.THER]Chemical Sciences/Medicinal ChemistryToxicologyAntiandrogenImidazolidinesNitric oxide03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineHydroxylaminemedicineAnimalsAnaerobiosisAmines030304 developmental biologychemistry.chemical_classification0303 health sciencesReactive oxygen speciesElectron Spin Resonance SpectroscopyImidazolesAndrogen AntagonistsGeneral MedicineRecombinant Proteins3. Good healthRatsAndrogen receptorEnzymechemistryBiochemistryCompetitive antagonist030220 oncology & carcinogenesisNilutamideCattleNitric Oxide SynthaseOxidation-ReductionNADPmedicine.drug
researchProduct

Enzymatically hydrolyzed low-density lipoprotein modulates inflammatory responses in endothelial cells

2009

SummaryThere is evidence that low-density lipoprotein (LDL) is modified by hydrolytic enzymes,and that the product (E-LDL) induces selective production of interleukin 8 (IL-8) in endothelial cells. Since nuclear factor-kappaB (NF-κB) is a major regulator of IL-8 transcription, we studied its activation in endothelial cells treated with E-LDL. Unexpectedly,the modified lipoprotein not only failed to activate NF-κB, but completely blocked its activation by tumour necrosis factor-alpha (TNF-α) in EA.hy926-cells, as assessed by electrophoretic mobility shift assays and immunofluorescence. Inhibition occurred upstream of NF-κB translocation, as inhibitor of NF-κB- (IκB)-phosphorylation was suppr…

Time FactorsProto-Oncogene Proteins c-junPyridinesmedicine.medical_treatmentFatty Acids NonesterifiedBiologyp38 Mitogen-Activated Protein KinasesCell Linechemistry.chemical_compoundNF-KappaB Inhibitor alphamedicineHumansTrypsinInterleukin 8PhosphorylationPromoter Regions GeneticProtein Kinase InhibitorsTranscription factorInflammationTumor Necrosis Factor-alphaActivator (genetics)HydrolysisInterleukin-8ImidazolesTranscription Factor RelAEndothelial CellsNF-κBHematologySterol EsteraseMolecular biologyLipoproteins LDLTranscription Factor AP-1Endothelial stem cellCytokineBiochemistrychemistryLow-density lipoproteinI-kappa B ProteinsLipoproteinThrombosis and Haemostasis
researchProduct

Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.

2004

1. A study performed > 10 years ago and case reports published recently suggest that triclabendazole is effective for the treatment of patients with fascioliasis. 2. To confirm the efficacy of a human formulation of triclabendazole, we enrolled 165 patients into the present study and divided the subjects into two groups: (i) those who had fascioliasis, as evidenced by the presence of ova in their stools; and (ii) patients with clinical and laboratory data suggesting fascioliasis. 3. Patients were randomly allocated to receive 10 mg/kg, p.o., triclabendazole for 1, 2 or 3 days (single-, double- and triple-dose groups, respectively). Medical history and physical and laboratory examinations we…

Toxic hepatitisAdultMalemedicine.medical_specialtyCure rateFascioliasisAdolescentPhysiologyChemistry PharmaceuticalGastroenterologylaw.inventionFecesRandomized controlled triallawOral administrationPhysiology (medical)Internal medicineMedicineHumansMedical historyIn patientChildTriclabendazoleAgedPharmacologyAnthelminticsDose-Response Relationship Drugbusiness.industryMiddle AgedSurgeryTriclabendazoleTreatment OutcomeHuman fascioliasisImmunoglobulin GBenzimidazolesFemalemedicine.symptombusinessmedicine.drugClinical and experimental pharmacologyphysiology
researchProduct

Cadmium effects on p38/MAPK isoforms in MDA-MB231 breast cancer cells

2009

Emerging evidence seems to indicate that the heavy metal cadmium (Cd) is able to regulate gene expression, drastically affecting the pattern of transcriptional activity in normal and pathological eukaryotic cells, also affecting intracellular signalization events. Human p38 is a family of mitogen-activated protein kinases consisting of four isoforms (alpha, beta, gamma and delta) which mediate signal transduction cascades controlling several aspects of cell physiology. In this study we examined whether exposure of MDA-MB231 tumor cells from the human breast to Cd may exert some effect on p38 isoform expression and accumulation, as well as on p38 activation. Employing a combination of prolif…

Transcriptional ActivationGene isoformCadmium SB203580 p38 isoforms p38 activation Gene expressionCell SurvivalPyridinesp38 mitogen-activated protein kinasesBreast NeoplasmsBiologyp38 Mitogen-Activated Protein KinasesGene Expression Regulation EnzymologicGeneral Biochemistry Genetics and Molecular BiologyBiomaterialsStructure-Activity RelationshipGene expressionTumor Cells CulturedHumansSettore BIO/06 - Anatomia Comparata E CitologiaCell ProliferationRegulation of gene expressionDose-Response Relationship DrugKinaseImidazolesMetals and AlloysMolecular biologyCell biologyIsoenzymesCell cultureDrug Screening Assays AntitumorSignal transductionGeneral Agricultural and Biological SciencesIntracellularCadmiumBioMetals
researchProduct

In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.

2010

The potent anti-tumour activities of gamma delta T cells have prompted the development of protocols in which gamma delta-agonists are administered to cancer patients. Encouraging results from small Phase I trials have fuelled efforts to characterize more clearly the application of this approach to unmet clinical needs such as metastatic carcinoma. To examine this approach in breast cancer, a Phase I trial was conducted in which zoledronate, a V gamma 9V delta 2 T cell agonist, plus low-dose interleukin (IL)-2 were administered to 10 therapeutically terminal, advanced metastatic breast cancer patients. Treatment was well tolerated and promoted the effector maturation of V gamma 9V delta 2 T …

Translational Studiesmedicine.medical_treatmentLymphocyte ActivationZoledronic AcidMetastasisTNF-Related Apoptosis-Inducing LigandProstate cancerT-Lymphocyte SubsetsImmunology and AllergyMedicineDiphosphonatesRemission InductionEsterasesImidazolesReceptors Antigen T-Cell gamma-deltaMiddle AgedMetastatic breast cancerTreatment Outcomemedicine.anatomical_structureDisease ProgressionCytokinesFemaleImmunotherapyBreast diseaseChemokinesT cellImmunologyBreast NeoplasmsInterferon-gammaHemiterpenesOrganophosphorus CompoundsBreast cancerAdjuvants ImmunologicVgamma9Vdelta2 T cells Zoledronate interleukin-2advanced breast cancer patientsHumansLymphocyte CountAgedCell ProliferationSalvage Therapybusiness.industryLysineMucin-1CancerImmunotherapymedicine.diseaseTumor Necrosis Factor Receptor Superfamily Member 7ImmunologyInterleukin-2Leukocyte Common Antigensbusiness
researchProduct

The impact of tumor nitric oxide production on VEGFA expression and tumor growth in a zebrafish rat glioma xenograft model.

2015

International audience; To investigate the effect of nitric oxide on tumor development, we established a rat tumor xenograft model in zebrafish embryos. The injected tumor cells formed masses in which nitric oxide production could be detected by the use of the cell-permeant DAF-FM-DA (diaminofluorophore 4-amino-5-methylamino-2'-7'-difluorofluorescein diacetate) and DAR-4M-AM (diaminorhodamine-4M). This method revealed that nitric oxide production could be co-localized with the tumor xenograft in 46% of the embryos. In 85% of these embryos, tumors were vascularized and blood vessels were observed on day 4 post injection. Furthermore, we demonstrated by qRT-PCR that the transplanted glioma ce…

Vascular Endothelial Growth Factor AMESH: Cyclin D1lcsh:MedicineMESH : Analysis of VarianceMESH: Flow Cytometry[ SDV.IMM.IA ] Life Sciences [q-bio]/Immunology/Adaptive immunologyBenzoates[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity[ SDV.CAN ] Life Sciences [q-bio]/CancerMESH: GliomaMESH: Reverse Transcriptase Polymerase Chain ReactionCyclin D1MESH: Animalslcsh:ScienceZebrafishMESH : RatsReverse Transcriptase Polymerase Chain ReactionMESH: Real-Time Polymerase Chain ReactionHistological TechniquesMESH : Reverse Transcriptase Polymerase Chain ReactionImidazolesGliomaMESH: Gene Expression Regulation NeoplasticFlow CytometryMESH : Cyclin D1Gene Expression Regulation NeoplasticMESH : Nitric Oxide[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunologyMESH : Vascular Endothelial Growth Factor AHeterograftsMESH : Histological TechniquesMESH: ImidazolesResearch ArticleMESH : BenzoatesMESH: RatsMESH : Flow CytometryMESH : Gene Expression Regulation NeoplasticMESH : Real-Time Polymerase Chain ReactionMESH : Zebrafish[SDV.CAN]Life Sciences [q-bio]/CancerMESH: Histological TechniquesMESH : HeterograftsNitric OxideReal-Time Polymerase Chain ReactionMESH : ImidazolesMESH: Analysis of VarianceAnimalsMESH: Zebrafish[ SDV.IMM.II ] Life Sciences [q-bio]/Immunology/Innate immunityAnalysis of VarianceMESH: Vascular Endothelial Growth Factor Alcsh:RMESH: BenzoatesRatsMESH : GliomaMESH: Nitric Oxidelcsh:QMESH: HeterograftsMESH : Animals
researchProduct

Multilayered supported ionic liquids as catalysts for chemical fixation of carbon dioxide

2011

Multilayered, covalently supported ionic liquid phase (mlc-SILP) materials were synthesized by using a new approach based on the grafting of bis-vinylimidazolium salts on different types of silica or polymeric supports. The obtained materials were characterized and tested as catalysts in the reaction of supercritical carbon dioxide with various epoxides to produce cyclic carbonates. The material prepared by supporting a bromide bis-imidazolium salt on the ordered mesoporous silica SBA-15 was identified as the most active catalyst for the synthesis of cyclic carbonates and displayed improved productivity compared with known supported ionic liquid catalysts. The catalyst retained its high act…

Vinyl CompoundsMaterials scienceGeneral Chemical EngineeringCatalyst supportIndustrial catalystsInorganic chemistryCarbonatesIonic LiquidsHeterogeneous catalysisCatalysisCatalysischemistry.chemical_compoundsupercritical carbon dioxideEnvironmental ChemistryGeneral Materials ScienceSupported ionic liquidSupercritical carbon dioxidecarbonate synthesiImidazolesSettore CHIM/06 - Chimica OrganicaCarbon DioxideMesoporous silicaSupercritical fluidGeneral EnergychemistryIonic liquidEpoxy CompoundsChemSusChem
researchProduct

Sea urchin deciliation induces thermoresistance and activates the p38 mitogen-activated protein kinase pathway.

2003

In this study, we demonstrate by a variety of approaches (ie, morphological analysis, Western blots, immunolocalization, and the use of specific antibodies) that hyperosmotic deciliation stress of sea urchin embryos induces a thermotolerant response. Deciliation is also able to activate a phosphorylation signaling cascade the effector of which might be the p38 stress-activated protein kinase because we found that the administration of the p38 inhibitor SB203580 to sea urchin deciliated gastrula embryos makes the hyperosmotic deciliation stress lethal.

animal structuresHot TemperaturePyridinesp38 mitogen-activated protein kinasesSEA URCHIN DECILIATION p38MAP KINASEBiochemistryp38 Mitogen-Activated Protein KinasesEnzyme activatorStress Physiologicalbiology.animalAnimalsCiliaSettore BIO/06 - Anatomia Comparata E CitologiaPhosphorylationProtein kinase ASea urchinbiologyEffectorImidazolesAntibodies MonoclonalCell BiologyGastrulaOriginal ArticlesMolecular biologyBlotEnzyme ActivationSea Urchinsembryonic structuresPhosphorylationElectrophoresis Polyacrylamide GelSignal transductionMitogen-Activated Protein KinasesSignal TransductionCell stresschaperones
researchProduct